Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Norursodeoxycholic acid

EU orphan designation number: EU/3/14/1288   
Active ingredient: Norursodeoxycholic acid
Indication: Treatment of primary sclerosing cholangitis
Sponsor: Dr Falk Pharma GmbH
Leinenweberstraße 5, 79041 Freiburg im Breisgau, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
8/07/2014 Orphan designation EMA/OD/026/14 (2014)4844 of 4/07/2014